QA and Clinical Enzymology – Study Notes (VETM*4490)

QA and Clinical Enzymology – Study Notes

• The material covers Quality Assurance (QA) in veterinary clinical pathology, with a focus on enzymology, pre-analytical and post-analytical processes, in-house versus commercial labs, reference intervals, and interpretation of enzymatic tests.

• It uses the Ontario Veterinary College (OVC) context and Beeler-Marfisi’s VETM*4490 course materials as the foundational content.

QA Program Overview

• Laboratory Quality Assurance Program definition:

  • Procedures and strategies to ensure that a laboratory reports trustworthy results.

  • QA programs assure both precision and accuracy of test results, e.g., use of run control samples.

  • It is CRITICAL that a laboratory has a quality control program.

• QA & Enzymology context: QA principles apply to enzymology labs just as they do to chemistry, hematology, etc.

Pre-Analytical Considerations – Part of QA, too

• Key steps before analysis that affect results:

  • Careful test selection

  • +/- Fasting

  • Correct collection tube

  • Order of fill

  • Adequate blood/serum volume

  • Proper collection technique

  • Correct labeling of tubes

  • Complete requisition form

  • Provide patient history

  • Correct storage/transport temperature (T°)

  • Time lapse before analysis

  • Always check with the laboratory prior to sending special samples

• Example data (illustrative pre-analytical variables and reference ranges):

  • ALB: $4.3000 \text{g/dL}$ (ref $2.5-4.4 \mathrm{g/dL}$)

  • ALP: <5 \text{IU/L} (ref $20-150 \mathrm{U/L}$)

  • ALT: $66 \text{IU/L}$ (ref $10-118 \mathrm{IU/L}$)

  • AMY: $432 \text{U/L}$ (ref $200-1200 \mathrm{U/L}$)

  • TBIL: $0.4000 \mathrm{mg/dL}$ (ref $0.1-0.6 \mathrm{mg/dL}$)

  • BUN: $14 \mathrm{mg/dL}$ (ref $7-25 \mathrm{mg/dL}$)

  • CA: $4.8000 \mathrm{mg/dL}$ (ref $8.6-11.8 \mathrm{mg/dL}$)

  • PHOS: $4.1000 \mathrm{mg/dL}$ (ref $2.9-6.6 \mathrm{mg/dL}$)

  • CRE: $1.3000 \mathrm{mg/dL}$ (ref $0.3-1.4 \mathrm{mg/dL}$)

  • GLU: $110 \mathrm{mg/dL}$ (ref $60-110 \mathrm{mg/dL}$)

  • NA⁺: $148 \mathrm{mmol/L}$ (ref $138-160 \mathrm{mmol/L}$)

  • K⁺: $4.9000 \mathrm{mmol/L}$ (ref $3.7-5.8 \mathrm{mmol/L}$)

  • Note: Some reference values include notes like elevation above reference (e.g., K⁺ >8.5 in a given lab context) indicating pathological or analytic issues; interpretation should consider the full clinical picture.

• Pre-analytical pitfalls can cause spurious results (e.g., EDTA contamination causing Ca and K abnormalities).

Post-Analytical Variables – Interpretation

• If something doesn’t fit, apply a workflow:

  • Confirm correct test was ordered for the clinical case.

  • Understand reference intervals and cut-points.

  • Consult with colleagues/pathologists when in doubt.

• Important interpretation principles:

  • Always interpret results in light of the clinical picture.

  • Be aware of potential EDTA contamination effects on serum tests.

  • Amylase can increase with decreased glomerular filtration rate (GFR).

  • Platelet clumps or artifacts may affect cell counts; review a peripheral blood smear when applicable.

  • Treat the patient, not the lab result.

• In-house vs external data handling:

  • Look for error messages on printouts to identify whether the fault lies with the sample, the user, or the instrument.

  • Consult user manuals and control charts/daily use logs; review notes from previous users.

  • Determine whether the machine itself is at fault and for how long the issue has persisted.

In-House Lab Operations vs External Labs

• In-House Testing: Advantages

  • Rapid turnaround time (TAT)

  • Control over when tests are performed

  • Potential to increase revenue

• In-House Testing: Disadvantages

  • Substantial upfront cost for hematology & chemistry systems (e.g., X \$ per the lecture: ext{often } \15-30k)

  • System capabilities limitations (single analyte vs full profile)

  • Dependence on external QA programs for some materials

  • Troubleshooting and need for specialized tests

  • Absence of a clinical pathologist in some settings

  • Hiring/training/retention costs for staff

  • In-house results may differ from reference laboratory results; ensure appropriate reference intervals and QA.

• Commercial Veterinary Laboratories: Advantages

  • Gold standard reference testing

  • Potentially lower per-test costs due to scale

  • Broad array of services and validated reference intervals

  • Access to a clinical pathologist and robust QA programs

• Commercial Laboratories: Disadvantages

  • Fixed turnaround times

  • Sample transport logistics and transportation costs

• Reference Intervals: Principles

  • May be supplied by equipment manufacturers, but should be generated by each lab

  • Cohort of clinically healthy animals should be used to establish reference intervals

  • Factors to consider: species, age, gender, husbandry, pregnancy status, health status

  • Ideally sample size > $100$ animals; minimum ~$40$

  • When assessing results, know the composition of the cohort used to generate the reference intervals

Enzymology – Background and Concepts

• Enzymes in tissues:

  • Cells contain enzymes; some serum activity is normal

  • Isoenzymes can occur in one or multiple tissues and can be differentially expressed

  • Increased serum enzyme activity can indicate tissue injury, reduced excretion, or increased production

• Ideal diagnostic enzyme (concept):

  • Measured in serum

  • Assay is simple to perform

  • Tissue/source is specific (single cell type)

  • Increase in activity indicates a clinical disease process

• Leakage vs Induced enzymes:

  • Leakage: enzymes released due to cell injury into plasma

  • Induced: increased production in response to stimuli; occurs days after stimulus

  • Tissue specificity and half-life (T½) influence interpretation

  • Handling/storage time affects preservation of activity

• Enzyme activity units and stability:

  • International Units per liter: $ext{IU/L}.$ (often abbreviated as $ext{U/L}$ or $ext{IU/L}$)

  • Enzyme activity decreases with time and temperature; important for remote/ambulatory practice

• Interpretation patterns:

  • ↑ Activity indicates tissue injury (leakage) or induction/production increase or decreased excretion

  • ↓ Activity is less commonly clinically significant in many contexts; steroids like prednisone can influence some enzymes

• Tissue specificity and localization:

  • Enzyme patterns help localize injury or production sources

  • Isoenzyme patterns and half-lives help distinguish tissue sources

• Isoenzymes and half-life differentiation:

  • ALP sources and half-lives provide clues to origin (e.g., liver, bone, intestine, placenta, kidney)

  • In dogs, ALP half-lives differ by tissue source (e.g., liver ~3 days; intestine ~6 minutes; placenta ~6 minutes; kidney ~6 minutes)

  • ALT, CK, GGT, and other enzymes have tissue-specific patterns that aid localization

• Route of excretion and assay methods:

  • Amylase and lipase excretion can be influenced by renal function; DGGR lipase is less affected by reduced renal excretion and may be more reliable in some contexts

  • Different assay methods (e.g., Method 1 vs Method 2 for lipase) can yield different results; interpret with assay method in mind

• Clinical history and case interpretation:

  • Clinical history can drastically impact interpretation (e.g., prednisone administration affecting ALP or GGT; hemolysis affecting AST, CK, etc.)

• Additional factors:

  • Biological variation (age, sex, species, breed, physiological status)

  • Drug effects (steroids, anticonvulsants)

  • Artifacts from collection, storage, transit time, and assay type

Enzyme Categories and Tissue Sources (Leakage vs Induced)

• Leakage enzymes (examples and sources):

  • ALT: hepatocytes, skeletal & cardiac muscle (extensive release with injury)

  • AST: hepatocytes, skeletal & cardiac muscle, RBCs

  • CK (CPK): skeletal & cardiac muscle

  • GLDH: hepatocytes (all animals; used in certain species)

  • SDH/IDH: hepatocytes (short half-life; used in large animals in some contexts)

  • Lipases: pancreatic acinar cells; hepatic tumors may influence levels

  • Amylase: pancreatic acinar cells; sometimes intestinal sources

  • ALP and GGT are more complex because ALP can be induced in several tissues (bone, liver, intestine; steroids) and GGT indicates biliary/hepatic epithelial involvement in many contexts

• Induced enzymes (examples):

  • ALP (induced by steroids, bone turnover, hepatic/bile duct involvement)

  • GGT (induced in biliary epithelium and hepatocytes with certain stimuli)

• Practical interpretation:

  • Pattern recognition of which tissues may be affected depending on which enzymes are elevated

  • Consider half-life and route of excretion when interpreting single time-point results

Interpreting Isoenzymes and Tissue Sources

• Differentiating isoenzymes by half-life (example):

  • ALP sources: liver, bone, intestine, placenta, kidney

  • In dogs, liver ALP has a longer half-life than intestinal ALP (intestine ~6 minutes) and placenta/other sources can have distinct kinetics

• Differentiating by other tissue-specific enzymes:

  • ALT vs ALP to distinguish liver vs bone sources in certain contexts

  • CK elevation with evidence of muscle damage

• Route of excretion and matrix considerations:

  • GGT elevations may indicate biliary disease

  • Amylase and lipase elevations can be confounded by renal function; DGGR lipase is often more robust in renal impairment

• Assay method considerations:

  • Different assay methods can yield different absolute values; compare to the same assay method or validate across methods

• Clinical history matters:

  • Drugs (e.g., prednisone) can influence enzyme levels

  • Hemolysis can artifactually elevate certain enzymes (e.g., CK, LDH)

Case-Based Notes and Examples

• Case concept: A dog with alkaline phosphatase elevation with multiple potential sources (liver, bone, steroid induction) requires integration of history, imaging, and additional enzymes (e.g., GGT, ALT) to localize source.

• Half-life interpretation: A rapid rise in CK and AST may indicate acute muscle injury; slower ALP rises may indicate bone turnover or steroid-induced induction, depending on the tissue source.

• Route of excretion: Amylase and lipase dynamics in cats/dogs can be influenced by renal function; consider DGGR lipase as a more kidney-independent option in some contexts.

• Assay method discrepancies: When lipase values differ between Method 1 and Method 2, review the methods; consider running diagnostics on the analyzer if discrepancies persist.

• Clinical history integration: A horse with AST elevations may be related to muscle injury or hepatic disease depending on the pattern of other enzymes and clinical signs; review blood smear and QA logs when in doubt.

Practical QA Questions and Concept Check (Selected from the Source)

• Why is QA important in a lab? Select all that apply.

  • A. Our clinic will make more money. (Not the primary aim; QA is about reliable results and value, not profit per se.)

  • B. An analyzer has a problem sooner rather than later. (True; QA helps catch problems early.)

  • C. Results are precise and accurate, i.e., trustworthy. (True; precision and accuracy are core QA goals.)

• What describes a precise test?

  • A. Correct result. (Not exactly; precision is about repeatability, not necessarily accuracy.)

  • B. Same result repeatedly. (True; precision means repeatable results.)

  • C. Same result as the control sample. (Not necessarily; could be repeatable but not match the control.)

  • D. Result within the reference interval. (Not necessarily; precision is about repeatability, not the reference range.)

• What describes an accurate test?

  • A. Correct result. (True; accuracy is closeness to the true value.)

  • B. Same result repeatedly. (That is precision.)

  • C. Same result as the control sample. (Not necessarily; control may differ from real samples.)

  • D. Result within the reference interval. (Not necessarily; accuracy refers to the true value, not the interval.)

• Pre-analytical QA issues (select all that apply):

  • A. Including a history. (True; aids interpretation.)

  • B. Filling the tube adequately. (True; improper filling can affect results such as CBC.)

  • C. Not keeping records on in-house analyzers. (True; often illegal/unsafe.)

  • D. Not having a QA program in place. (True; essential for trustworthiness.)

  • E. Selecting the correct blood tube for testing. (True; tube type matters.)

  • F. Knowing storage/transport requirements. (True; affects sample integrity.)

• A QA scenario: Cat with acute vomiting and unexpected Ca and K values likely due to EDTA contamination; steps include checking tube filling, opting to redraw, and interpreting results in context; do not over-treat based on spurious results alone.

• Wellness panel in a horse with platelets read as low: consider blood smear and QA log to evaluate for platelet clumping and analyzer errors; avoid transfusion based solely on reading.

Summary Takeaways

• A robust QA program is essential to ensure test results are trustworthy (precise and accurate) and to support high-quality veterinary care.

• Pre-analytical and post-analytical phases significantly influence test results and interpretation; careful technique, appropriate tests, and clinical context are critical.

• In-house and commercial labs each have advantages and drawbacks; the choice depends on TAT, cost, reference intervals, QA capabilities, and staff expertise.

• Enzymology requires understanding the biology of enzymes (leakage versus induction, isoenzymes, half-lives, tissue specificity) and the impact of handling/storage on activity.

• Case interpretation relies on integrating enzyme patterns, species-specific data, assay methods, and clinical history; always corroborate lab data with the clinical picture and ancillary tests (e.g., blood smears, QA logs).

• Practice questions and discussions provided in the material reinforce concepts of QA, precision vs accuracy, pre-analytical factors, and interpretation of enzyme data.

References to Course Content (Key Points)

• QA and Enzymology lecture notes (Beeler-Marfisi, VETM*4490)

• Concepts covered in slides relating to:

  • QA program purpose and components

  • Pre-analytical and post-analytical variables

  • In-house vs commercial laboratories and reference intervals

  • Enzymology fundamentals: leakage vs induced enzymes, isoenzymes, half-life, route of excretion, assay methods, and interpretation

  • Case-based interpretation guidance and QA practices

• Practice quiz items and answers emphasizing QA concepts, precision vs accuracy, pre-analytical issues, and interpretation in real cases